New York, United States, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Continuous positive airway pressure (CPAP) devices are used to treat obstructive sleep apnea disorder. The device increases the air pressure in the throat so that airways do not collapse when breathing. Rising numbers of patients with sleep apnea, obesity, and other respiratory disorders prompt the dire need for effective CPAP devices. As per the World Health Organization (WHO), globally, over 1.9 billion adults aged 18 and above were overweight in 2016. The report suggests that in 2016, more than 340 million children and adolescents aged 5–19 were overweight or obese.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/cpap-devices-market/request-sample
Impact of COVID-19
The emergence of this pandemic has severely impacted the global economy, causing instability in the environment and supply chain. Lack of ventilators has compelled the healthcare workers to look for alternatives in order to offer respiratory treatment to patients afflicted by COVID-19, further driving the adoption of CPAP devices.Essential modifications required to convert CPAP devices to treat respiratory inadequacy have been designed to minimalize aerosolization. These factors play an significant role in boosting the continuous development of the successful airway pressure devices market. Recently, ResMedannounced plans to maximize the availability of respiratory support devices to treat COVID-19 patients.
Report Scope
| Report Metric | Details |
| Market Size | USD 5254.51 million by 2030 |
| CAGR | 7.4% (2022-2030) |
| Historical Data | 2019-2020 |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, End-User, Regions |
| Geographies Covered | North America, Europe, Asia-Pacific, LAME and Rest of the World |
| Key Companies Profiled/Vendors | Medtronic Plc., Smiths Group plc., Koninklijke Philips N.V., Draegerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, Hamilton Medical AG, ResMed Inc., DeVilbiss Healthcare LLC., 3B Medical, Inc., BMC Medical Co. Ltd. |
| Key Market Opportunities | Rising Technological Advancements and Initiatives of Key Manufacturers |
| Key Market Drivers | Growing Global Burden of Sleep Apnea and Rising Government Initiatives |
Buy Now Full Report @ https://straitsresearch.com/buy-now/cpap-devices-market
Regional Analysis
North America dominated the market for CPAP devices in 2019 and is expected to continue to do so during the forecast period. Strong healthcare infrastructure and major healthcare businesses who are substantially investing in R&D operations to address the rising prevalence of sleep apnea support the region.
Due to the region's quickly growing healthcare infrastructure, soaring healthcare spending, rising R&D efforts, and soaring demand for technologically advanced CPAP devices in nations like South Korea and India, Asia-Pacific is predicted to have the fastest growth in the CPAP devices market.
Key Highlights
- The global CPAP devices market Size is projected to reach USD 5254.51 million by 2030 at a CAGR of 7.4% from 2022 to 2030.
- Rising demand for positive airway pressure devices for home use drives the home care settings segment growth
- North America dominates the CPAP devices market as the region is backed by the presence of leading insurance providers and robust healthcare facilities.
Key Players
- Medtronic Plc.
- Smiths Group plc.
- Koninklijke Philips N.V.
- Draegerwerk AG & Co. KGaA
- Fisher & Paykel Healthcare
- Hamilton Medical AG
- ResMed Inc.
- DeVilbiss Healthcare LLC.
- 3B Medical, Inc.
- BMC Medical Co. Ltd.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/cpap-devices-market/request-sample
CPAP Devices Market: Segmentation
By Product
- CPAP Devices
- CPAP Humidifier
- CPAP Masks
- Accessories
By End-User
- Hospital
- Clinic
- Sleep Centre
- Home Care Setting
By Region
- North America
- Europe
- Asia-Pacific
- Central and South America and the Caribbean
- The Middle-East and Africa
TABLE OF CONTENT
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: CPAP Devices Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
3.6 Top Wining Strategies
3.7 Top Investment Pockets
3.8 Impact of COVID-19
4 Product Overview
4.1 Introduction
4.1.1 Market Size & Forecast (Value)
4.2 CPAP Devices
4.2.1 Market Size & Forecast (Value)
4.3 CPAP Humidifier
4.3.1 Market Size & Forecast (Value)
4.4 CPAP Masks
4.4.1 Market Size & Forecast (Value)
4.5 Accessories
4.5.1 Market Size & Forecast (Value)
5 End-User Overview
5.1 Introduction
5.1.1 Market Size & Forecast (Value)
5.2 Hospitals
5.2.1 Market Size & Forecast (Value)
5.3 Clinics
5.3.1 Market Size & Forecast (Value)
5.4 Sleep Centers
5.4.1 Market Size & Forecast (Value)
5.5 Home Care Settings
5.5.1 Market Size & Forecast (Value)
6 Regional Overview
6.1 Introduction
6.1.1 Market Size & Forecast (Value)
6.2 North America
6.2.1 North America
6.2.1.1 The U.S.
6.2.1.1.1 By Product
6.2.1.1.2 By End-User
6.2.1.2 Canada
6.2.1.2.1 By Product
6.2.1.2.2 By End-User
6.2.1.3 Mexico
6.2.1.3.1 By Product
6.2.1.3.2 By End-User
6.2.2 Central South America and the Caribbean
6.2.2.1 By Product
6.2.2.2 By End-User
6.2.2.2.1 Brazil
6.2.2.2.1.1 By Product
6.2.2.2.1.2 By End-User
6.2.2.2.2 Argentina
6.2.2.2.2.1 By Product
6.2.2.2.2.2 By End-User
6.2.2.2.3 The Rest of Central South America and the Caribbean
6.2.2.2.3.1 By Product
6.2.2.2.3.2 By End-User
6.3 Europe
6.3.1 Market Size & Forecast (Value)
6.3.2 Western Europe
6.3.2.1 The U.K.
6.3.2.1.1 By Product
6.3.2.1.2 By End-User
6.3.2.2 Germany
6.3.2.2.1 By Product
6.3.2.2.2 By End-User
6.3.2.3 France
6.3.2.3.1 By Product
6.3.2.3.2 By End-User
6.3.2.4 Spain
6.3.2.4.1 By Product
6.3.2.4.2 By End-User
6.3.2.5 Italy
6.3.2.5.1 By Product
6.3.2.5.2 By End-User
6.3.2.6 The Rest of Western Europe
6.3.2.6.1 By Product
6.3.2.6.2 By End-User
6.3.3 Eastern Europe
6.3.3.1 By Product
6.3.3.2 By End-User
6.3.4 The Rest of Europe
6.3.4.1 By Product
6.3.4.2 By End-User
6.4 Asia Pacific
6.4.1 Market Size & Forecast (Value)
6.4.2 Japan
6.4.2.1 By Product
6.4.2.2 By End-User
6.4.3 China
6.4.3.1 By Product
6.4.3.2 By End-User
6.4.4 Australia
6.4.4.1 By Product
6.4.4.2 By End-User
6.4.5 India
6.4.5.1 By Product
6.4.5.2 By End-User
6.4.6 South Korea
6.4.6.1 By Product
6.4.6.2 By End-User
6.4.7 The Rest of Asia-Pacific
6.4.7.1 By Product
6.4.7.2 By End-User
6.5 The Middle East and Africa
6.5.1 The Middle East
6.5.1.1 Market Size & Forecast (Value)
6.5.1.2 Saudi Arabia
6.5.1.2.1 By Product
6.5.1.2.2 By End-User
6.5.1.3 The UAE
6.5.1.3.1 By Product
6.5.1.3.2 By End-User
6.5.1.4 Qatar
6.5.1.4.1 By Product
6.5.1.4.2 By End-User
6.5.2 The Africa
6.5.2.1 Market Size & Forecast (Value)
7 Company Profile
7.1 Medtronic Plc.
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Recent Developments
7.1.4 Product Portfolio
7.2 Smiths Group plc.
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Recent Developments
7.2.4 Product Portfolio
7.3 Koninklijke Philips N.V.
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Recent Developments
7.3.4 Product Portfolio
7.4 Draegerwerk AG & Co. KGaA
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Recent Developments
7.4.4 Product Portfolio
7.5 Fisher & Paykel Healthcare
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Recent Developments
7.5.4 Product Portfolio
7.6 Hamilton Medical AG
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Recent Developments
7.6.4 Product Portfolio
7.7 ResMed Inc.
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Recent Developments
7.7.4 Product Portfolio
7.8 DeVilbiss Healthcare LLC
7.8.1 Company Overview
7.8.2 Financial Performance
7.8.3 Recent Developments
7.8.4 Product Portfolio
7.9 3B Medical, Inc.
7.9.1 Company Overview
7.9.2 Financial Performance
7.9.3 Recent Developments
7.9.4 Product Portfolio
7.10 BMC Medical Co. Ltd
7.10.1 Company Overview
7.10.2 Financial Performance
7.10.3 Recent Developments
7.10.4 Product Portfolio
8 Conclusion & Recommendations
9 Acronyms & Abbreviations
Table of Content and Figure @ https://straitsresearch.com/report/cpap-devices-market/toc
Recent Developments
- In April 2019, ResMed launched AirFit N30i, its first top-of-head-connected nasal CPAP mask across the U.S. with a newly designed nasal cradle cushion that sits under the wearer’s nose
- In 2016, Koninklijke Philips (the Netherlands) launched its Dream Family solution, which comprises a DreamWear mask, DreamStation PAP device, and DreamMapper patient engagement app
News Media
Home Care Sleep Screening Devices Market to Reach USD 550.17 Million by 2026 at a CAGR of 7.1%
Have a Look at the Related Research Report?
Positive Airway Pressure Devices Market: Information by Product Type (Automatic Positive Airway Pressure (APAP) Devices), End-User (Home Care), and Region — Forecast till 2030
Airway Management Devices Market: Information by Product (Supraglottic Devices, Infraglottic Devices), Application (Anesthesia), End-User (Hospital, Homecare), and Region — Forecast till 2029
Therapeutic Respirator Devices Market: Information by Product (Nebulizers, Humidifiers), Technology (Electrostatic Filtration), Filter (Nebulizer Filter), and Region — Forecast till 2029
Home Care Service Market: Information by Service (Maid Services, Carpet & Upholstery), Duration (Daily, Weekly), and Region- Forecast till 2030
Home Care Sleep Screening Devices Market: Information by Type (Wearables and Non-Wearables), Sales Channel (Retail store and Online), and Region — Forecast till 2026
About Straits Research Pvt. Ltd.
StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.
For more information on your target market, please contact us below:
Phone: +1 646 480 7505 (the U.S.)
+91 8087085354 (APAC)
+44 208 068 9665 (the U.K.)
Email: sales@straitsresearch.com
Follow Us: LinkedIn | Facebook | Instagram | Twitter
